Vaxcyte, Inc. — Director's Dealing 2023

Oct 16, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2023-10-12

Reporting Person: Wassil Jim (Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-10-12	Common Stock	M	5000	$2.42	Acquired	175935	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2023-10-12	Stock Option (right to buy)	$2.42	M	5000	Disposed	2029-12-16	Common Stock (5000)	Direct

Footnotes

F1: 1/4 of the shares subject to the option vested on December 1, 2020, and 1/48 of the shares vest monthly thereafter.